Author:
Cai Ruoqing,Tressler Caitlin M.,Cheng Menglin,Sonkar Kanchan,Tan Zheqiong,Paidi Santosh Kumar,Ayyappan Vinay,Barman Ishan,Glunde Kristine
Abstract
AbstractThe premetastatic niche hypothesis proposes an active priming of the metastatic site by factors secreted from the primary tumor prior to the arrival of the first cancer cells. We investigated several extracellular matrix (ECM) structural proteins, ECM degrading enzymes, and ECM processing proteins involved in the ECM remodeling of the premetastatic niche. Our in vitro model consisted of lung fibroblasts, which were exposed to factors secreted by nonmalignant breast epithelial cells, nonmetastatic breast cancer cells, or metastatic breast cancer cells. We assessed ECM remodeling in vivo in premetastatic lungs of female mice growing orthotopic primary breast tumor xenografts, as compared to lungs of control mice without tumors. Premetastatic lungs contained significantly upregulated Collagen (Col) Col4A5, matrix metalloproteinases (MMPs) MMP9 and MMP14, and decreased levels of MMP13 and lysyl oxidase (LOX) as compared to control lungs. These in vivo findings were consistent with several of our in vitro cell culture findings, which showed elevated Col14A1, Col4A5, glypican-1 (GPC1) and decreased Col5A1 and Col15A1 for ECM structural proteins, increased MMP2, MMP3, and MMP14 for ECM degrading enzymes, and decreased LOX, LOXL2, and prolyl 4-hydroxylase alpha-1 (P4HA1) for ECM processing proteins in lung fibroblasts conditioned with metastatic breast cancer cell media as compared to control. Taken together, our data show that premetastatic priming of lungs by primary breast tumors resulted in significant ECM remodeling which could facilitate metastasis by increasing interstitial fibrillar collagens and ECM stiffness (Col14A1), disruptions of basement membranes (Col4A5), and formation of leaky blood vessels (MMP2, MMP3, MMP9, and MMP14) to promote metastasis.
Funder
National Institutes of Health
National Science Foundation of China, China
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Wormann, B. Breast cancer: basics, screening, diagnostics and treatment. Med. Monatsschr. Pharm. 40, 55–64 (2017).
2. Jin, L. et al. Breast cancer lung metastasis: Molecular biology and therapeutic implications. Cancer Biol. Ther. 19, 858–868. https://doi.org/10.1080/15384047.2018.1456599 (2018).
3. Paget, S. The distribution of secondary growths in cancer of the breast 1889. Cancer Metastasis Rev. 8, 98–101 (1989).
4. Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820–827. https://doi.org/10.1038/nature04186 (2005).
5. Liu, Y. & Cao, X. Characteristics and significance of the pre-metastatic Niche. Cancer Cell 30, 668–681. https://doi.org/10.1016/j.ccell.2016.09.011 (2016).